Top compounds associated with response to RP11-729L2.2


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.003
mRNA NVP-ADW742 CTRPv2 pan-cancer AAC 0.11 0.004
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.004
mRNA ML239 CTRPv2 pan-cancer AAC 0.11 0.004
mRNA STF-31 CTRPv2 pan-cancer AAC 0.11 0.004
mRNA DBeQ CTRPv2 pan-cancer AAC 0.11 0.004
mRNA phloretin CTRPv2 pan-cancer AAC 0.11 0.005
mRNA KH-CB19 CTRPv2 pan-cancer AAC 0.14 0.005
mRNA PRIMA-1-Met CTRPv2 pan-cancer AAC 0.16 0.005
mRNA GSK-J4 CTRPv2 pan-cancer AAC 0.32 0.005
Download CSV